Exact Mass: 534.1795
Exact Mass Matches: 534.1795
Found 500 metabolites which its exact mass value is equals to given mass value 534.1795
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(-)-Arctiin
Natural compounds from herbs are recognized as an important source of therapeutic agents. Seeking for natural products with high selectivity and less side effects merits considerable efforts. Arctium lappa, also known as burdock, is widely consumed in East Asia, Europe and America to promote well-being for hundreds of years. In Chinese traditional medicine, Arctium lappa (mainly roots, and, to a less extend, seeds and leaves) is an important herbal medicinal preparation. It is commonly used for alleviating symptoms of inflammatory disorders, such as anemopyretic cold, cough, measles, urticaria and furuncle (Shin et al., 2015; Zhao et al., 2009). In addition, Arctium lappa is applied to treat various skin disorders including eczema and acne (Chan et al., 2011; Miglani and Manchanda, 2014). Lignans are the most characteristic phytoconstituents of Arctium lappa. Among them, ATG (Formula:C21H24O6; PubChem CID:64,981) and its glycoside, arctiin are the major bioactive compounds (Fig. 1). ATG, rich in roots and seeds of Arctium lappa, has attracted a great deal of attention due to its prominent therapeutic potential. It possesses many biological activities such as anti-oxidative stress (Lü et al., 2016), anti-cancer (He et al., 2018; Shabgah et al., 2021), anti-virus (Gao et al., 2018a) and anti-inflammation (Hyam et al., 2013; Zhao et al., 2009). Significant curative effects of ATG have been demonstrated on a wide range of human diseases including cancers, autoimmune disorders, chronic diseases, viral infections and other health concerns. The bioactivity of ATG largely depend on its chemical structure. For instance, the chiral carbon atom in the lactone ring is essential for the anti-tumor effect of ATG as (–)-arctigenin exhibits greater tumor suppression effect than (+)-arctigenin (Awale et al., 2014). Furthermore, the dibenzyl butyrolactone is key for the interactions between ATG and proteins. (-)-arctiin is a member of the class of compounds known as lignan glycosides. Lignan glycosides are aromatic polycyclic compounds containing a carbohydrate component glycosidically linked to a lignan moiety. They include 1-aryltetralin lactones (-)-arctiin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (-)-arctiin can be found in burdock, which makes (-)-arctiin a potential biomarker for the consumption of this food product. Arctiin is a glycoside and a lignan. Arctiin is a natural product found in Abeliophyllum distichum, Forsythia suspensa, and other organisms with data available. Arctiin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=20362-31-6 (retrieved 2024-06-28) (CAS RN: 20362-31-6). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Arctiin (NSC 315527) is a plant lignan extracted from burdock seeds and has anti-cancer activity. Arctiin (NSC 315527) is a plant lignan extracted from burdock seeds and has anti-cancer activity.
Phillyrin
Forsythin is a lignan and a glycoside. Phillyrin is a natural product found in Forsythia suspensa, Phillyrea latifolia, and other organisms with data available. Annotation level-1 2-[4-[3-(3,4-Dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol is a natural product found in Pteris semipinnata with data available. Phillyrin is isolated from Forsythia suspensa Vahl (Oleaceae), has antibacterial and anti-inflammatory activities. Phillyrin has potential inductive effects on rat CYP1A2 and CYP2D1 activities, without affecting CYP2C11 and CYP3A1/2 activities[1]. Phillyrin has anti-influenza A virus activities[2]. Phillyrin is isolated from Forsythia suspensa Vahl (Oleaceae), has antibacterial and anti-inflammatory activities. Phillyrin has potential inductive effects on rat CYP1A2 and CYP2D1 activities, without affecting CYP2C11 and CYP3A1/2 activities[1]. Phillyrin has anti-influenza A virus activities[2].
CERCOSPORIN
An organic heterohexacyclic compound that is perylo[1,12-def][1,3]dioxepine-6,11-dione substituted by hydroxy groups at positions 5 and 12, by methoxy groups at positions 7 and 10, and by 2-hydroxypropyl groups at positions 8 and 9 (the R,R-stereoisomer). It is a phytotoxin which was first isolated from the pathogenic soybean fungus, Cercospora kikuchii and later found in multiple members of the genus Cercospora. CONFIDENCE isolated standard
Aprepitant
Aprepitant, an antiemetic, is a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. Aprepitant has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting (CI NV). A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Aprepitant (MK-0869) is a selective and high-affinity neurokinin 1 receptor antagonist with a Kd of 86 pM.
Isosyringinoside
Isosyringinoside is found in herbs and spices. Isosyringinoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). Isosyringinoside is found in herbs and spices.
Myricatomentoside II
Myricatomentoside II is found in brassicas. Myricatomentoside II is a constituent of Myrica gale var. tomentosa
6-Carboxy-X-rhodamine
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines
Delamanid
ent-Aprepitant
piperaquine
Ruberythric acid
Sulfosuccinimidyl 6-(biotinamido)hexanoate
6,8-Di-C-beta-D-arabinopyranosylapigenin
6,8-di-c-beta-d-arabinopyranosylapigenin is a member of the class of compounds known as flavonoid 8-c-glycosides. Flavonoid 8-c-glycosides are compounds containing a carbohydrate moiety which is C-glycosidically linked to 8-position of a 2-phenylchromen-4-one flavonoid backbone. 6,8-di-c-beta-d-arabinopyranosylapigenin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 6,8-di-c-beta-d-arabinopyranosylapigenin can be found in tea, which makes 6,8-di-c-beta-d-arabinopyranosylapigenin a potential biomarker for the consumption of this food product.
Rimegepant
N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CD - Calcitonin gene-related peptide (cgrp) antagonists C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
Apigenin 6-C-α-L-arabinopyranosyl-8-C-β-D-xylopyranoside
Apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-xylopyranoside is a natural product found in Viola philippica with data available.
Styraxlignolide F
Styraxlignolide F is a natural product found in Styrax japonicus with data available. Styraxlignolide F is a natural compoundisolated from Styrax japonica. Styraxlignolide F is a natural compoundisolated from Styrax japonica.
Styraxlignolide
Styraxlignolide F is a natural product found in Styrax japonicus with data available. Styraxlignolide F is a natural compoundisolated from Styrax japonica. Styraxlignolide F is a natural compoundisolated from Styrax japonica.
5,7,4-Trihydroxyflavone 6-C-xylopyranoside-8-C-arabinopyranoside
3,4,7-Trihydroxy-5-methoxy-8-prenylflavan 7-O-beta-D-glucopyranoside
(+)-Pinoresinol monomethyl ether O-beta-D-glucopyranoside
3,5,7,3,4-Pentahydroxy-6-prenylflavanone 7-glucoside
Parthenosin
Okanin 4-O-(4,6-di-O-acetylglucoside)
6,9-Dihydroxy-2,310-trimethoxy-6a,12a-didehydrorotenone 9-O-glucoside
6-C-alpha-L-Arabinopyranosyl-8-C-beta-L-arabinopyranosylapigenin
6-O-beta-L-Arabinopyranosyl-8-C-alpha-L-arabinopyranosylapigenin
5,7-Dihydroxy-6-C-methylflavanone 7-xylosyl- (1->3) -xyloside
Aerucyclamide A
CONFIDENCE standard compound; UCHEM_ID 4363; NaToxAq - Natural Toxins and Drinking Water Quality - From Source to Tap (https://natoxaq.ku.dk)
3,4,l-O-3,4-Dimethoxy-phenylethyl-6-O-cinnamoyl-??-D-glucopyranose
epiphyllic acid-7-O-beta-glucoside-10-methyl ester
2-O-[6-O-(5-O-syringoyl-beta-D-apiofuranosyl)-beta-D-glucopyranosyl]isopropyl alchohol|2-O-[6-O-(5-O-syringoyl-beta-D-apiofuranosyl)-beta-D-glucopyranosyl]isopropyl alcohol|eryciboside G
3t-[6-(tetra-O-acetyl-beta-D-glucopyranosyloxy)-benzofuran-5-yl]-acrylic acid|3t-[6-(Tetra-O-acetyl-beta-D-glucopyranosyloxy)-benzofuran-5-yl]-acrylsaeure|psoralic acid-(6<--1)-O-beta-D-glucopyranoside acetate
(1S,3S,6R,7R,8R,10S)-1(10)-Epoxy-3-hydroxy-8-<5-(5-acetoxy-4-hydroxytiglyloxy)-tiglyloxy>helianga-5,11(13)-dien-6,12-olide|(1S,3S,6R,7R,8R,10S)-1(10)-Epoxy-3-hydroxy-8-[5-(5-acetoxy-4-hydroxytiglyloxy)-tiglyloxy]helianga-5,11(13)-dien-6,12-olide
apigenin-7-O-beta-D-apiofuranosyl-(1->2)-beta-D-apiofuranoside
6-beta-C-(2-galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone|6-beta-C-(2-O-galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone|6-??-C-(2-Galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone
1-O-[(E)-3,4-dihydroxy-5-methoxycinnamoyl]gentiobiose
(3R)-trans-3-(4-beta-D-Glucopyranosyloxy-3-methoxy-benzyl)-4-veratryl-dihydro-furan-2-on|(3R)-trans-3-(4-beta-D-glucopyranosyloxy-3-methoxy-benzyl)-4-veratryl-dihydro-furan-2-one
methyl 1alpha,6,8alpha,14beta,30beta-pentahydroxy-3-oxo-[3.3.110,2.11,4]-tricyclomeliac-7-oate
5,7-Dihydroxy-6-C-methylflavanone 7-xylosyl-(1->3)-xyloside
8-beta-C-(2-galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone|8-beta-C-(2-O-galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone|8-??-C-(2-Galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone
4,5-di-O-(4-hydroxy-3,5-methoxy-benzoyl)-shikimic acid
2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-7-methoxybenzofuran-5-propenoic acid 4-O-beta-D-glucopyranoside|aegineoside
2-(3-methylbutyryl)phloroglucinol-4,6-di-C-beta-D-glucopyranoside
2,5-dihydroxy-4-methoxyphenanthrene 2-O-beta-D-apiofuranosyl-(1-6)-beta-D-glucopyranoside|denneanoside E
(S(a),6S,7S,8S)-6-[(benzoyl)oxy]-6,7,8,9,9,18,18-heptahydro-1,2,3,14-tetramethoxy-8-methyl-spiro[dibenzo[a,c]cyclooctene-7,17-oxirane]|schisandrin A1|schisphenlignan D
(5S)-6-O-(3,4-dimethoxy cinnamoyl)-1-O-beta-D-glucopyranosyl-geraniol-10,5-olide|sibiraglycoside A
(- )-(3S)-3-hydroxy-alpha-ericadione 3-O-beta-D-glucopyranoside|1-(p-hydroxyphenyl)-9-(3,4-dihydroxyphenyl)-3-hydroxynonan-5,6-dione 3-O-b-D-glucopyranoside|3-hydroxy-alpha-ericadione 3-glucoside|3-hydroxy-alpha-ericadione 3-O-beta-D-glucoside
4-O-(beta-D-Arabinopyranosl-beta-D-galactopyranoside)- 3,4-Dihydroxychalcone
genipin 1-O-alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranoside
6-O-p-coumaroylgeniposide|6-O-trans-p-coumaroylgeniposide
Me glycoside,2,3-O-isopropylidene,tri-Ac,Me ester-4-O-beta-D-Glucopyranuronosyl-L-rhamnose
Hexa-Ac-beta-Pyranose-4-O-alpha-D-Xylopyranosyl-D-xylose|Hexa-Ac-beta-Pyranose-Xylobiose
2, 4, 5, 7, 8, 9-Hexa-Ac, Me ester-3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid, 9CI
Me glycoside,penta-Ac-4-O-alpha-L-Fucopyranosyl-L-fucose
Thr Tyr His Asp
Tyr Ser His Glu
3,4-Dihydroxychalcone 4-beta-L-arabinopyranosyl-(1->4)-galactoside
Aprepitant
A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Aprepitant (MK-0869) is a selective and high-affinity neurokinin 1 receptor antagonist with a Kd of 86 pM.
Moexipril HCl
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Conivaptan HCl
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents
Arctiin
Annotation level-1 Arctiin (NSC 315527) is a plant lignan extracted from burdock seeds and has anti-cancer activity. Arctiin (NSC 315527) is a plant lignan extracted from burdock seeds and has anti-cancer activity.
C26H30O12_Cyclopenta[c]pyran-4-carboxylic acid, 1,4a,5,7a-tetrahydro-7-(hydroxymethyl)-1-[[6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-beta-D-glucopyranosyl]oxy]-, methyl ester
C23H34O14_(2E)-3-[4-(beta-D-Glucopyranosyloxy)-3,5-dimethoxyphenyl]-2-propen-1-yl beta-D-glucopyranoside
C27H34O11_beta-D-xylo-Hexopyranoside, 4-[(1S,3aR,4S,6aR)-4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenyl, (4xi)
(2R,3R,4S,5S,6R)-2-[(E)-3-[3,5-dimethoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2-[4-[(3R,3aR,6S,6aR)-3-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol
2-[4-[(3R,3aR,6S,6aR)-3-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major
2-[4-[(3R,3aR,6S,6aR)-3-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_82.5\\%
2-[4-[(3R,3aR,6S,6aR)-3-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_minor
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol_major
(2R,3R,4S,5S,6R)-2-[(E)-3-[3,5-dimethoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major
Cys Cys Phe Tyr
Cys Cys Tyr Phe
Cys Glu Phe His
Cys Glu His Phe
Cys Phe Cys Tyr
Cys Phe Glu His
Cys Phe His Glu
Cys Phe Tyr Cys
Cys His Glu Phe
Cys His Phe Glu
Cys Ser Tyr Tyr
Cys Tyr Cys Phe
Cys Tyr Phe Cys
Cys Tyr Ser Tyr
Cys Tyr Tyr Ser
Asp His Thr Tyr
Asp His Tyr Thr
Asp Asn Thr Trp
Asp Asn Trp Thr
Asp Gln Ser Trp
Asp Gln Trp Ser
Asp Ser Gln Trp
Asp Ser Trp Gln
Asp Thr His Tyr
Asp Thr Asn Trp
Asp Thr Trp Asn
Asp Thr Tyr His
Asp Trp Asn Thr
Asp Trp Gln Ser
Asp Trp Ser Gln
Asp Trp Thr Asn
Asp Tyr His Thr
Asp Tyr Thr His
Glu Cys Phe His
Glu Cys His Phe
Glu Glu Glu Glu
Glu Phe Cys His
Glu Phe His Cys
Glu His Cys Phe
Glu His Phe Cys
Glu His Ser Tyr
Glu His Tyr Ser
Glu Met Gln Gln
Glu Asn Ser Trp
Glu Asn Trp Ser
Glu Gln Met Gln
Glu Gln Gln Met
Glu Ser His Tyr
Glu Ser Asn Trp
Glu Ser Trp Asn
Glu Ser Tyr His
Glu Trp Asn Ser
Glu Trp Ser Asn
Glu Tyr His Ser
Glu Tyr Ser His
Phe Cys Cys Tyr
Phe Cys Glu His
Phe Cys His Glu
Phe Cys Tyr Cys
Phe Glu Cys His
Phe Glu His Cys
Phe His Cys Glu
Phe His Glu Cys
Phe Tyr Cys Cys
His Cys Glu Phe
His Cys Phe Glu
His Asp Thr Tyr
His Asp Tyr Thr
His Glu Cys Phe
His Glu Phe Cys
His Glu Ser Tyr
His Glu Tyr Ser
His Phe Cys Glu
His Phe Glu Cys
His Ser Glu Tyr
His Ser Tyr Glu
His Thr Asp Tyr
His Thr Tyr Asp
His Tyr Asp Thr
His Tyr Glu Ser
His Tyr Ser Glu
His Tyr Thr Asp
Met Glu Gln Gln
Met Gln Glu Gln
Met Gln Gln Glu
Asn Asp Thr Trp
Asn Asp Trp Thr
Asn Glu Ser Trp
Asn Glu Trp Ser
Asn Ser Glu Trp
Asn Ser Trp Glu
Asn Thr Asp Trp
Asn Thr Trp Asp
Asn Trp Asp Thr
Asn Trp Glu Ser
Asn Trp Ser Glu
Asn Trp Thr Asp
Gln Asp Ser Trp
Gln Asp Trp Ser
Gln Glu Met Gln
Gln Glu Gln Met
Gln Met Glu Gln
Gln Met Gln Glu
Gln Gln Glu Met
Gln Gln Met Glu
Gln Ser Asp Trp
Gln Ser Trp Asp
Gln Trp Asp Ser
Gln Trp Ser Asp
Ser Cys Tyr Tyr
Ser Asp Gln Trp
Ser Asp Trp Gln
Ser Glu His Tyr
Ser Glu Asn Trp
Ser Glu Trp Asn
Ser Glu Tyr His
Ser His Glu Tyr
Ser His Tyr Glu
Ser Asn Glu Trp
Ser Asn Trp Glu
Ser Gln Asp Trp
Ser Gln Trp Asp
Ser Trp Asp Gln
Ser Trp Glu Asn
Ser Trp Asn Glu
Ser Trp Gln Asp
Ser Tyr Cys Tyr
Ser Tyr Glu His
Ser Tyr His Glu
Ser Tyr Tyr Cys
Thr Asp His Tyr
Thr Asp Asn Trp
Thr Asp Trp Asn
Thr Asp Tyr His
Thr His Asp Tyr
Thr His Tyr Asp
Thr Asn Asp Trp
Thr Asn Trp Asp
Thr Trp Asp Asn
Thr Trp Asn Asp
Thr Tyr Asp His
Trp Asp Asn Thr
Trp Asp Gln Ser
Trp Asp Ser Gln
Trp Asp Thr Asn
Trp Glu Asn Ser
Trp Glu Ser Asn
Trp Asn Asp Thr
Trp Asn Glu Ser
Trp Asn Ser Glu
Trp Asn Thr Asp
Trp Gln Asp Ser
Trp Gln Ser Asp
Trp Ser Asp Gln
Trp Ser Glu Asn
Trp Ser Asn Glu
Trp Ser Gln Asp
Trp Thr Asp Asn
Trp Thr Asn Asp
Tyr Cys Cys Phe
Tyr Cys Phe Cys
Tyr Cys Ser Tyr
Tyr Cys Tyr Ser
Tyr Asp His Thr
Tyr Asp Thr His
Tyr Glu His Ser
Tyr Glu Ser His
Tyr Phe Cys Cys
Tyr His Asp Thr
Tyr His Glu Ser
Tyr His Ser Glu
Tyr His Thr Asp
Tyr Ser Cys Tyr
Tyr Ser Glu His
Tyr Ser Tyr Cys
Tyr Thr Asp His
Tyr Thr His Asp
Tyr Tyr Cys Ser
Tyr Tyr Ser Cys
Myricatomentoside II
Isosyringinoside
Delamanid
J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent
piperaquine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
1-methyl-5-[2-(4-methylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)sulfonylthiophen-3-yl]-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one
5-ROX
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines
Trisiloxane, 3,3-(1,2-ethanediyl)bis[3-[(diMethylsilyl)oxy]-1,1,5,5-tetraMethyl-
9-(naphthalen-2-yl)-9-phenyl-9H,9H-3,3-bicarbazole
5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
Rimegepant
N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CD - Calcitonin gene-related peptide (cgrp) antagonists C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
6-[3-Fluoro-4-(trifluoromethyl)phenyl]-3-({2-[3-(4-methylpiperazin-1-yl)propoxy]pyrimidin-5-yl}amino)pyrazine-2-carboxamide
Ethyl 2-[4-[(7-chloro-4-quinolyl)amino]butylamino]-4-methyl-6-(2-nitrophenyl)pyrimidine-5-carboxylate
N-[(1R,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
1-benzoyl-N-[3-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]amino]propyl]-2-methyl-1-azaspiro[4.5]dec-3-ene-2-carboxamide
2-[(2S,4aR,12aR)-5-methyl-8-[[(4-methylanilino)-oxomethyl]amino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2,2,2-trifluoroethyl)acetamide
2-[(2R,4aS,12aS)-5-methyl-8-[[(4-methylanilino)-oxomethyl]amino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2,2,2-trifluoroethyl)acetamide
N-[[(4R,5S)-8-(3-cyanophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4S,5R)-8-(3-cyanophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[(1R,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
2-[(2R,4aR,12aS)-5-methyl-8-[[(4-methylanilino)-oxomethyl]amino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2,2,2-trifluoroethyl)acetamide
N-[[(4S,5R)-8-(3-cyanophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4R,5R)-8-(3-cyanophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4S,5S)-8-(3-cyanophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4R,5S)-8-(3-cyanophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4R,5R)-8-(3-cyanophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4S,5S)-8-(3-cyanophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[(1S,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(2R,4aS,12aS)-2-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-5-isoxazolecarboxamide
2-[(2R,4aS,12aR)-5-methyl-8-[[(4-methylanilino)-oxomethyl]amino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2,2,2-trifluoroethyl)acetamide
2-[(2S,4aR,12aS)-5-methyl-8-[[(4-methylanilino)-oxomethyl]amino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2,2,2-trifluoroethyl)acetamide
6-[2-[2-(2,4-Dihydroxyphenyl)-2-oxoethyl]-5-hydroxy-3-methoxy-4-(3-methylbut-2-enyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[(8,11-Dihydroxy-17-methoxy-10-oxo-2-oxatricyclo[13.2.2.13,7]icosa-1(17),3,5,7(20),15,18-hexaen-4-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[4-[2-(2,4-Dihydroxyphenyl)-2-oxoethyl]-5-hydroxy-3-methoxy-2-(3-methylbut-2-enyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
Forsythin
Phillyrin is isolated from Forsythia suspensa Vahl (Oleaceae), has antibacterial and anti-inflammatory activities. Phillyrin has potential inductive effects on rat CYP1A2 and CYP2D1 activities, without affecting CYP2C11 and CYP3A1/2 activities[1]. Phillyrin has anti-influenza A virus activities[2]. Phillyrin is isolated from Forsythia suspensa Vahl (Oleaceae), has antibacterial and anti-inflammatory activities. Phillyrin has potential inductive effects on rat CYP1A2 and CYP2D1 activities, without affecting CYP2C11 and CYP3A1/2 activities[1]. Phillyrin has anti-influenza A virus activities[2].
2,6-Dimethoxy-4-[(E)-3-(beta-D-glucopyranosyloxy)-1-propenyl]phenyl beta-D-glucopyranoside
(4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]oxolan-2-one
1,2,3,4-Cyclopentanetetracarboxylic acid tetra(trimethylsilyl) ester
2-(3,4-Dimethoxyphenyl)ethyl 4-O-(DI-O-methylcaffeoyl)-1beta-(D)-glucopyranoside
2-(3,4-Dimethoxyphenyl)ethyl 6-O-(DI-O-methylcaffeoyl)-beta-(D)-glucopyranoside
BMS-986188
BMS-986188 is a selective positive allosteric modulator of δ-opioid receptor with an EC50 of 0.05 μM[1].
UPGL00004
UPGL00004 is a potent allosteric glutaminase C (GAC) inhibitor (IC50=29 nM; Kd=27 nM). UPGL00004 strongly inhibits the proliferation of highly aggressive triple-negative breast cancer cell lines[1].
8-[(1r,2r)-2-hydroxy-1-{[(1s,2r)-2-hydroxy-1-(7-methoxy-2-oxochromen-8-yl)-3-methylbut-3-en-1-yl]oxy}-3-methylbut-3-en-1-yl]-7-methoxychromen-2-one
4-[6-(acetyloxy)-2,2-dimethylbenzo[h]chromen-5-yl]-2,2-dimethylbenzo[h]chromen-6-yl acetate
{3,4,5-trihydroxy-6-[3-(3-oxo-1h-2-benzofuran-1-yl)propoxy]oxan-2-yl}methyl 2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)acetate
3-[(2r,3r,4ar,6s,7s,8s,8ar)-2-(3,4-dimethoxyphenyl)-7,8-dihydroxy-6-(hydroxymethyl)-hexahydro-2h-pyrano[2,3-b][1,4]dioxin-3-yl]-1-(3,4-dimethoxyphenyl)propan-1-one
methyl (2s,3r,4r,5s,6r)-3-(acetyloxy)-2-hydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylate
2-{[3,4-dihydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 2-[6-(furan-3-yl)-10,11,12,17-tetrahydroxy-1,5,15-trimethyl-8,14-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadecan-18-yl]-2-hydroxyacetate
[(9s)-4,5,9-trihydroxy-10-oxo-9-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-2-yl]methyl (2r,3s)-3-hydroxy-2-methylbutanoate
7-methyl-4,18-bis(sec-butyl)-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-2,5(24),9,12(23),14,16,19(22)-heptaene-2,9,16-triol
methyl 2-[(1r,2r,4s,7r,8s,10s,11r,12r,13r,16r)-10-hydroxy-7-(5-hydroxy-2-oxo-5h-furan-3-yl)-1,8,12,15,15-pentamethyl-5,18-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-13-yl]acetate
22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1(30),2,4(34),10,12,14(37),16,18,25,27,32,35-dodecaene-13,27-diol
2-(1-{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy}hexyl)-1,3,6,8-tetrahydroxyanthracene-9,10-dione
9,17-dihydroxy-5,21-bis(2-hydroxypropyl)-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1(15),2,4(22),5,8,10,16,18(23),20-nonaene-7,19-dione
7,19-dihydroxy-5,21-bis[(2s)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione
(2s,3s,4s,5r,6r)-2-{4-[(1s,3ar,4s,6ar)-4-(3,4-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
1,5-bis(3,4-dihydroxyphenyl)-4-pentyne-1,2-diol; (1r,2r)-form,1-butyl ether,2-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN001641","Ingredient_name": "1,5-bis(3,4-dihydroxyphenyl)-4-pentyne-1,2-diol; (1r,2r)-form,1-butyl ether,2-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C27H34O11","Ingredient_Smile": "NA","Ingredient_weight": "534.55","OB_score": "NA","CAS_id": "186202-05-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9512","PubChem_id": "NA","DrugBank_id": "NA"}
1,5-bis(3,4-dihydroxyphenyl)-4-pentyne-1,2-diol; (1s,2s)-form,1-butyl ether,2-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN001645","Ingredient_name": "1,5-bis(3,4-dihydroxyphenyl)-4-pentyne-1,2-diol; (1s,2s)-form,1-butyl ether,2-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C27H34O11","Ingredient_Smile": "NA","Ingredient_weight": "534.55","OB_score": "NA","CAS_id": "186202-09-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9508","PubChem_id": "NA","DrugBank_id": "NA"}
3,4,l-o-3,4-dimethoxy-phenylethyl-6-o-cinnamoyl-β-d-glucopyranose
{"Ingredient_id": "HBIN007489","Ingredient_name": "3,4,l-o-3,4-dimethoxy-phenylethyl-6-o-cinnamoyl-\u03b2-d-glucopyranose","Alias": "NA","Ingredient_formula": "C27H34O11","Ingredient_Smile": "COC1=C(C=C(C=C1)CCOC2C(C(C(C(O2)CO)OC(=O)C=CC3=CC(=C(C=C3)OC)OC)O)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6283","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-methoxyarctii-4''-o-β-d-xyloside
{"Ingredient_id": "HBIN008818","Ingredient_name": "3-methoxyarctii-4''-o-\u03b2-d-xyloside","Alias": "NA","Ingredient_formula": "C27H34O11","Ingredient_Smile": "COC1=C(C=C(C=C1)CC2(COC(=O)C2CC3=CC(=C(C=C3)OC4C(C(C(CO4)O)O)O)OC)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13834","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-γ,γ-dimethylallyltaxifolin 7-o-β-d-glucoside
{"Ingredient_id": "HBIN012842","Ingredient_name": "6-\u03b3,\u03b3-dimethylallyltaxifolin 7-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C26H30O12","Ingredient_Smile": "CC(=CCC1=C(C=C2C(=C1O)C(=O)C(C(O2)C3=CC(=C(C=C3)O)O)O)OC4C(C(C(C(O4)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6310","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bismurrangatin
{"Ingredient_id": "HBIN018631","Ingredient_name": "bismurrangatin","Alias": "NA","Ingredient_formula": "C30H30O9","Ingredient_Smile": "CC(=C)C(C(C1=C(C=CC2=C1OC(=O)C=C2)OC)OC(C3=C(C=CC4=C3OC(=O)C=C4)OC)C(C(=C)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2485","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}